Company Overview
Amdocs Limited, through its subsidiaries, provides software and services to communications, entertainment, media, and other service providers worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud offering. The company also provides CES25, a telco-native, GenAI-led customer experience suite, spanning business, and operations and network domains that is embedded with AI and related tools. In addition, it offers GenAI agents, and which include Customer Engagement Platform, a telecom-specific customer relationship management (CRM) solution; Amdocs Monetization Suite which enables customers to monetize their broad set of services and offerings; Amdocs Intelligent Networking Suite, a set of solutions that provide end-to-end service orchestration; Amdocs Charging; Amdocs eSIM Cloud that enables service providers to offer digital SIM (eSIM); Amdocs MarketONE, a based Software-as-a-Service (SaaS)-based platform that includes pre-integrated digital services, ranging from media, gaming, eLearning, sports and retail to security, and business services; and Amdocs connectX, a cloud-native telco-in-a-box software-as-a-service platform for digital telecom brands, as well as Amdocs CatalogONE that spans the entire CES25 suite and combines embedded business intelligence with telecom-specific GenAI agents. Further, the company provides consulting, experience design, data, cloud, network services, delivery, quality engineering, operations, systems integration, and content services to various platforms and technologies; maintenance, enhancement design and development, and operational support services; network deployment and optimization services; and managed services, including AI and related tools, predictive analytics, and robotic process automation, as well as quality engineering, mobile network, cloud, and professional services. Amdocs Limited was founded in 1982 and is headquartered in Saint Louis, Missouri.
Why Investors Should Care
Return on capital employed stands at 16.6%.
Trades at a P/E of 14.2, below the sector median of 29.2.
Operating margin of 18.0% supports profitability.
Carries low leverage with a debt-to-equity ratio of 0.33.
Offers a dividend yield of 3.66%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Sep 2025 Revenue of $4.53B (-9.4% YoY); net profit $564.70M.
- Trailing 12 Months Year-on-year growth — revenue +2.7%, earnings -57.4%.
- 5-Year Trend Long-term compounding — revenue CAGR -0.3%, profit CAGR 0.9%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -0.32% |
| 1 Year: | 2.70% |
Compounded Profit Growth
| 5 Years: | 0.91% |
| 1 Year: | -57.40% |
Stock Price Performance
| 1 Year: | -30.05% |
| 6 Months: | -11.67% |
| 3 Months: | +3.94% |
| 1 Month: | +2.43% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)50.18 · Neutral
P/E of 14.24 is below the sector median of 29.22 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Attractive dividend yield of 3.66%.
- Generates positive free cash flow.
CONS
- Revenue declined at -0.3% CAGR over 5 years.
- Trading 30.1% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Technology).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | DOX Amdocs Limited R3KTECH | 59.97 | 14.24 | $6.26B | 3.66% | 16.61% | 13.31% | -0.32% | 0.91% |
| 2 | NVDA NVIDIA Corporation NDXSPXR3KAITECH | 225.73 | 28.50 | $5.45T | 0.46% | 74.66% | 117.21% | 24.64% | 32.12% |
| 3 | AAPL Apple Inc. NDXSPXR3KTECH | 316.22 | 36.22 | $4.61T | 0.34% | 68.72% | 148.75% | 1.81% | 3.92% |
| 4 | MSFT Microsoft Corporation NDXSPXR3KAITECH | 493.95 | 27.49 | $3.67T | 0.79% | 26.33% | 34.04% | 9.93% | 11.90% |
| 5 | TSM Taiwan Semiconductor Manufacturing Company Limited AITECH | 439.00 | 32.71 | $2.28T | 0.95% | 30.20% | 39.97% | 18.94% | 19.57% |
| 6 | AVGO Broadcom Inc. NDXSPXR3KAITECH | 368.56 | 46.95 | $1.75T | 0.71% | 16.70% | 44.25% | 17.04% | 54.08% |
| 7 | MU Micron Technology, Inc. NDXSPXR3KAITECH | 1,000.26 | 22.59 | $1.13T | 0.05% | 13.69% | 66.64% | 13.68% | 26.02% |
| 8 | AMD Advanced Micro Devices, Inc. NDXSPXR3KAITECH | 505.74 | 128.36 | $825.61B | 0.00% | 5.47% | 10.20% | 11.81% | 66.28% |
| 9 | ASML ASML Holding N.V. NDXAITECH | 1,764.85 | 59.89 | $677.88B | 0.51% | 42.97% | 53.94% | 15.55% | 19.55% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 1.13B | 1.14B | 1.15B | 1.16B | 1.17B |
| Cost of Revenue | - | 698.05M | 711.15M | 719.88M | 727.72M | 716.73M |
| Gross Profit | - | 430.15M | 433.29M | 430.34M | 428.22M | 455.25M |
| Operating Expenses | - | 232.42M | 230.82M | 223.96M | 210.23M | 261.99M |
| Operating Income | - | 197.74M | 202.47M | 206.38M | 217.98M | 193.26M |
| EBITDA | - | 245.23M | 250.47M | 189.62M | 257.42M | 235.87M |
| Interest Expense | - | 8.46M | 11.71M | 15.86M | 11.27M | 5.96M |
| Pretax Income | - | 189.27M | 190.76M | 120.78M | 195.42M | 176.89M |
| Tax Provision | - | 25.27M | 35.96M | 23.67M | 36.96M | 38.12M |
| Net Income | - | 163.24M | 154.00M | 96.33M | 157.57M | 137.81M |
| Diluted EPS | - | 1.45 | 1.39 | 0.88 | 1.45 | 1.28 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Revenue | - | 4.58B | 4.89B | 5.00B | 4.53B |
| Cost of Revenue | - | 2.96B | 3.16B | 3.25B | 2.81B |
| Gross Profit | - | 1.62B | 1.73B | 1.76B | 1.72B |
| Operating Expenses | - | 954.35M | 1.00B | 995.70M | 909.38M |
| Operating Income | - | 664.80M | 724.89M | 759.70M | 812.20M |
| EBITDA | - | 889.85M | 857.41M | 821.20M | 931.11M |
| Interest Expense | - | 16.91M | 23.09M | 34.89M | 42.44M |
| Pretax Income | - | 648.41M | 636.36M | 591.07M | 693.24M |
| Tax Provision | - | 98.91M | 93.40M | 94.75M | 125.47M |
| Net Income | - | 549.50M | 540.71M | 493.20M | 564.70M |
| Diluted EPS | - | 4.44 | 4.49 | 4.25 | 5.05 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 6.39B | 6.43B | 6.39B | 6.25B |
| Current Assets | - | 2.00B | 1.91B | 1.77B | 1.59B |
| Cash & Equivalents | - | 573.38M | 520.08M | 346.08M | 325.00M |
| Inventory | - | - | - | - | - |
| Receivables | - | 789.61M | 732.98M | 665.74M | 589.78M |
| Total Liabilities | - | 2.83B | 2.86B | 2.89B | 2.78B |
| Current Liabilities | - | 1.25B | 1.35B | 1.47B | 1.36B |
| Long Term Debt | - | 645.12M | 645.70M | 646.29M | 646.90M |
| Total Debt | - | 826.83M | 807.31M | 789.74M | 826.40M |
| Total Equity | - | 3.52B | 3.52B | 3.46B | 3.43B |
| Shares Outstanding | - | 284.40M | 286.33M | 288.48M | 290.35M |
Cash Flows (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 756.72M | 822.63M | 724.43M | 749.10M |
| Investing Cash Flow | - | -262.50M | -224.50M | -127.41M | -2.06M |
| Financing Cash Flow | - | -629.90M | -651.43M | -771.02M | -768.12M |
| Capital Expenditure | - | -227.22M | -124.36M | -105.50M | -103.95M |
| Free Cash Flow | - | 529.50M | 698.27M | 618.93M | 645.14M |
| Net Change in Cash | - | -135.69M | -53.30M | -174.00M | -21.09M |
Ratios (Annual)
Figures in %.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 35.4% | 35.3% | 35.1% | 38.0% |
| Operating Margin % | - | 14.5% | 14.8% | 15.2% | 17.9% |
| Net Margin % | - | 12.0% | 11.1% | 9.9% | 12.5% |
| ROE % | - | 15.6% | 15.3% | 14.3% | 16.5% |
| ROCE % | - | 12.9% | 14.3% | 15.5% | 16.6% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Pzena Investment Management LLC | 12.96% | 13.99M | $829.33M |
| 2 | FMR, LLC | 9.29% | 10.03M | $594.92M |
| 3 | Beutel, Goodman & Company Ltd | 4.27% | 4.61M | $273.62M |
| 4 | Brandes Investment Partners L.P. | 4.24% | 4.58M | $271.69M |
| 5 | LSV Asset Management | 4.18% | 4.51M | $267.48M |
| 6 | Blackrock Inc. | 4.05% | 4.38M | $259.46M |
| 7 | Dimensional Fund Advisors LP | 3.79% | 4.10M | $242.90M |
| 8 | Federated Hermes, Inc. | 2.91% | 3.14M | $186.35M |
| 9 | Vanguard Portfolio Management LLC | 2.55% | 2.75M | $163.25M |
| 10 | AQR Capital Management, LLC | 2.44% | 2.63M | $155.96M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for DOX
Amdocs (DOX) Stock Still Looks Like A Bargain After Weak Returns - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxQUzBMNmRhT0NUWnZQSzV1VE84N0NpTDZDanRMaGFrY3prZk54LXdoRXJOcXpLc1ZUc3BPS00wM3lIOGtTV0dZX0VVc2pCTTdGQUJxNnpHMFZzTkZnbzJUbEZhRU1pY0dBVHItU3NUMlktZVlaZEVuamFIUW1ubXRsSFMzdURrQjNUVTFadj…
Amdocs (DOX) Stock Trades Up, Here Is Why - StockStory
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxNcC1ZZW5LVHJlUDF1eUdWTkt2LVdMZ2trTGhMdmZvMGpETmtPZEJBRUd5dkp3a19YcWhPLTlTd2hoU0RZbVNsV1BJQ1JqODRhWG9kaDVTVmVPbmV5emNHMFhhUE8wLUxISXZydjBsTmM0bHF0VWIxNklBMzlVWjEtSzh6MTZOazZFRHVBRz…
Two Amdocs executives will speak at Goldman Sachs and Citi events - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxQRnZtTk5ZZWlPNU41Y3J5UHlPYUUtMy0zN0ktMGcwX1hfazhFSHA5cjAySGxrbEMxSW1rdEpzNGJkMHpLcWxmLXhIbkVtWF9mM0lvWktpN1pGVm85TlVLUEpidmJoNVBFSzBEM2YyaW95NHViUlVLRWZQc3RfOHhmS0JWUVZmWFFxRURGN1…
Why Is Amdocs (DOX) Up 7% Since Last Earnings Report? - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxOUzdYUjk0NTJQRThFUjlNYjFIMzVGa1ItQzVjU3FaTjYxS1FHSklnNnRzWDBtZktVVzM0VDBZbmQ4dE9tWTlCVGlmRmdoSFpBWUt3ZGhrZ3dUNWdBX2owWXVBbkxHSGRuRmNPRGpieWQtbmYyMU1FeTFsbFdRYWVJMWJ0UzlnVWZuaDE5MF…
Amdocs Ltd (NASDAQ:DOX): A Deep Value Stock with Strong Fundamentals - ChartMill
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxNUkpOb2FmRUJiaTVTMFlnOEw1ckY0ZUhPa3o4TloyV2FSMUNSMWZmN2dHMFNsejFRVlZwVnhKSnFtWUlmOHFvS1BYWmRhRmJBamQzUXRqa3l3RjZSd2NKMENaYmVoRUhMWmNGQjhLZG5VMnJJRDdWeXNUb3BrWTd5U2VEZUtuN2ZGODc0eT…
Amdocs Offers A Clear Value Case - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMifkFVX3lxTE1HU1hDbUpUZzh1RDdmbnJnZWRDTlh2U1dYZWJqWUpTSUlta0JtR2tsUGdoQ014X05UMFNFbkJHNFhVYzZVZWhUak9UcDdFaTIzMXpGWTBWamMyNzY5ZUhYZ0FOdGdXREZ1eHlaRUZtU05ULUxpUU03SzFvdmI1dw?oc=5" target="_blan…
DOX — Frequently Asked Questions
What is the current share price of Amdocs Limited (DOX)?
As of 2026-09-19 21:16 PDT, Amdocs Limited (DOX) trades at $59.97 on NasdaqGS. Its 52-week range is $49.32 to $85.73.
What is the market capitalisation of DOX?
Amdocs Limited (DOX) has a market capitalisation of $6.26B on NasdaqGS.
What is the P/E ratio of DOX?
DOX trades at a trailing price-to-earnings (P/E) ratio of 14.24. The industry average P/E is 29.22. Its price-to-book (P/B) ratio is 1.90.
Does DOX pay a dividend?
Amdocs Limited (DOX) currently offers a dividend yield of 3.66%.
What is the return on equity (ROE) of DOX?
DOX has a return on equity (ROE) of 13.31%. Its return on capital employed (ROCE) is 16.61%.
Is DOX a good stock to buy?
This page provides a data-driven analysis of Amdocs Limited (DOX), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.